Clinical Trial Detail

NCT ID NCT03844620
Title Circulating Cell-Free Tumor DNA Testing in Guiding Treatment for Patients With Advanced or Metastatic Colorectal Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

colorectal cancer

Therapies

Regorafenib

trifluridine/tipiracil hydrochloride

Regorafenib + trifluridine/tipiracil hydrochloride

Age Groups: senior adult

No variant requirements are available.